Thread by @FlavioCadegiani

PUBLISHED. We have just published our 2nd large study of the effects of ivermectin as prophylaxis for COVID-19 in Itajaí, Santa Catarina, Brazil. Link: cureus.com/articles/11185…

While in the 1st study we evaluated whether the use of ivermectin could impact in COVID-19 infection and mortality rates, in this study we evaluated whether the regular use and the total amount of ivermectin used could bring additional benefits.

We observed that among who used ivermectin, those who used ivermectin regularly every 15 days at a dose of 1cp of 6mg for every 30kg of body weight for 2 consecutive days for at least 6 to 8 weeks had up to a 92% reduction in mortality compared to those who did not.

We showed a dose-response effect, that is, the more you used, the more protection you had, which reinforces the conclusions regarding ivermectin efficacy.

In the 2nd study, I acted as the senior researcher, that coordinated and headed the analysis of the study. I am honored to have led the analysis of the study designed by the great Prof. Lucy Kerr.

I, Flavio Cadegiani, have afforded all editorial costs without receiving absolutely any additional penny for these purposes.

I hope you enjoy the reading.

Flavio Cadegiani